Cabozantinib in Hepatocellular Carcinoma
Clinical trial NCT04588051 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04588051
- Sponsor
- Stephen Chan Lam
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2027-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.